Skip to main content
Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.650
+0.150 (4.29%)
At close: Mar 9, 2026, 4:00 PM EDT
3.670
+0.020 (0.55%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Ironwood Pharmaceuticals Revenue

In the year 2025, Ironwood Pharmaceuticals had annual revenue of $296.15M, down -15.72%. Ironwood Pharmaceuticals had revenue of $47.71M in the quarter ending December 31, 2025, a decrease of -47.31%.

Revenue (ttm)
$296.15M
Revenue Growth
-15.72%
P/S Ratio
2.01
Revenue / Employee
$2,961,510
Employees
100
Market Cap
595.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025296.15M-55.26M-15.72%
Dec 31, 2024351.41M-91.33M-20.63%
Dec 31, 2023442.74M32.14M7.83%
Dec 31, 2022410.60M-3.16M-0.76%
Dec 31, 2021413.75M24.23M6.22%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 837.32M
Emergent BioSolutions 742.90M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Esperion Therapeutics 303.80M
Canopy Growth 203.04M
Kamada 174.79M
SIGA Technologies 172.25M
Revenue Rankings

IRWD News

More News